Momar Toure
Casma Therapeutics (United States)(US)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments
Most-Cited Works
- → The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study(2017)650 cited
- → Small‐Molecule PROTACS: New Approaches to Protein Degradation(2016)622 cited
- → Modular PROTAC Design for the Degradation of Oncogenic BCR‐ABL(2015)613 cited
- → Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation(2018)363 cited
- → Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and Degradation(2017)173 cited
- → Design, synthesis and biological evaluation of Proteolysis Targeting Chimeras (PROTACs) as a BTK degraders with improved pharmacokinetic properties(2019)89 cited
- → Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure–Degradation Relationships(2018)52 cited
- → Targeted protein unfolding uncovers a Golgi-specific transcriptional stress response(2018)46 cited
- → Niedermolekulare PROTACs: neue Wege zum Abbau von Proteinen(2016)40 cited
- → Asymmetric Rhodium-Directed anti-Markovnikov Regioselective Boracyclopentannulation(2012)39 cited